![Chemical structure of 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide, CAS 50-18-0](https://api.angenesci.com/structure/1028/50-18-0.png)
No data
No data
No data
| CAS Number | 50-18-0 |
| Catalog Number | AG00I8WU(AGN-PC-0S6UBQ) |
| Chemical Name | 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide |
| EC Number | 200-015-4 |
| IUPAC Name | N,N-bis(2-chloroethyl)-2-oxo-1,3,2λ5-oxazaphosphinan-2-amine |
| InChI | InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12) |
| InChI Key | CMSMOCZEIVJLDB-UHFFFAOYSA-N |
| MDL Number | MFCD00149395 |
| Molecular Formula | C7H15Cl2N2O2P |
| Molecular Weight | 261.0860 |
| RTECS Number | RP5950000 |
| SMILES | ClCCN(P1(OCCCN1)=O)CCCl |
| Synonyms | (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,
B 518,
B-518,
B518,
Cyclophosphamide,
Cyclophosphamide Anhydrous,
Cyclophosphamide Monohydrate,
Cyclophosphamide, (R)-Isomer,
Cyclophosphamide, (S)-Isomer,
Cyclophosphane,
Cytophosphan,
Cytophosphane,
Cytoxan,
Endoxan,
Neosar,
NSC 26271,
NSC-26271,
NSC26271,
Procytox,
Sendoxan,
cyclophosphamide,
50-18-0,
Cyclophosphamid,
Cyclophosphane,
Cytophosphan,
Procytox,
Clafen,
Cytoxan,
Endoxan,
Neosar,
Cyclophosphamidum,
Cyclophosphan,
Cyclostin,
Sendoxan,
Cytophosphane,
Claphene,
Endoxana,
Endoxanal,
Genoxal,
Endoxan-Asta,
Endoxan R,
Zyklophosphamid,
Mitoxan,
(RS)-Cyclophosphamide,
Cyclophosphoramide,
Cyklofosfamid,
Endoxane,
Enduxan,
Semdoxan,
Senduxan,
(+-)-Cyclophosphamide,
Ciclofosfamida,
Cyclofosphamide,
Cyclophosphanum,
Ciclophosphamide,
Lyophilized Cytoxan,
Cyclophosphamide anhydrous,
Rcra waste number U058,
Asta B 518,
Cycloblastin,
D,L-Cyclophosphamide,
ASTA,
Cyklofosfamid [Czech],
Ciclophosphamide [INN],
NSC 26271,
Zyklophosphamid [German],
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester,
B 518,
CB 4564,
NCI-C04900,
Cyclophosphamide (anhydrous),
SK 20501,
ASTA B518,
Ciclofosfamida [INN-Spanish],
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide,
NSC-26271,
Cyclophosphamidum [INN-Latin],
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide,
Occupation, cyclophosphamide exposure,
CCRIS 188,
Revimmune,
(-)-Cyclophosphamide,
4-Hydroxy-cyclophosphan-mamophosphatide,
CHEBI:4027,
Cyclophosphamide (anhydrous form),
HSDB 3047,
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
NSC26271,
Cytoxan (TN),
EINECS 200-015-4,
RCRA waste no. U058,
BRN 0011744,
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide,
AI3-26198,
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin,
2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide,
CMSMOCZEIVJLDB-UHFFFAOYSA-N,
N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide,
N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide,
Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester,
CY,
N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine,
N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester diamide,
N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide,
EN300-74526,
2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazophosphorine 2-oxide,
N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid [German],
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+-)-,
W-105248,
Cyclophosphamides,
Cytoxan Lyoph,
2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide,
Cyclophosphamide (TN),
Cyclophosphamide Sterile,
Cyclophosphamide (INN),
Clafen(Cyclophosphamide),
SR-01000075737,
NCGC00015209-05,
Cyclophosphamide [USP:INN],
Ciclofosfamide,
Ledoxina,
2-(Bis(2-chloroethyl)amino)-2H-1,2-oxazaphosphorine 2-oxide,
2-[Bis(2-chloroethyl)amino]-2H-1,2-oxazaphosphorine 2-oxide,
B-518,
Cyclophosphamide, (+-)-Isomer,
Lyophilizedcytoxan,
(Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate,
[Bis(chloro-2-ethyl)amino]-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate,
60007-96-7,
CB-4564,
Spectrum_000858,
AC1L1EQQ,
Anhydrous cyclophosphamide,
CHEMBL88,
Spectrum2_001146,
Spectrum3_000370,
Spectrum4_000304,
Spectrum5_000795,
Clafen(Cyclophosphamide)/,
Lopac-C-0768,
Epitope ID:131782,
C 0768,
SCHEMBL4346,
(.+/-.)-Cyclophosphamide,
Lopac0_000238,
BSPBio_002099,
KBioGR_000888,
KBioSS_001338,
bis(2-Chloroethyl)phosphami de cyclic propanolamide,
ARONIS24566,
DivK1c_000246,
SPBio_001071,
GTPL7154,
SCHEMBL4345553,
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester,
DTXSID5020364,
SCHEMBL10262910,
CMSMOCZEIVJLDB-UHFFFAOYSA-,
CTK2F5582,
KBio1_000246,
KBio2_001338,
KBio2_003906,
KBio2_006474,
KBio3_001319,
KS-00000XHN,
BBC/739,
CYCLOPHOSPAMIDE MONOHYDRATE,
WLN: T6MPOTJ BO BN2G2G,
NINDS_000246,
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine,
HMS2090A12,
HMS3260P17,
HMS3715J05,
Pharmakon1600-01500213,
BCP02139,
ZX-AS004939,
Tox21_500238,
ABP000629,
BBL022697,
MFCD00005978,
N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid,
NSC273033,
NSC273034,
NSC756711,
STK177249,
AKOS005410738,
AN-6966,
API0002151,
CS-1425,
DB00531,
LP00238,
LS-1302,
MCULE-5327530727,
NSC-273033,
NSC-273034,
NSC-756711,
(+-)-N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
IDI1_000246,
N,3,2-oxazaphosphorin-2-amine-2-oxide,
N,O-propylen-phosphorsaeure-ester-diamid,
NCGC00015209-01,
NCGC00015209-02,
NCGC00015209-03,
NCGC00015209-04,
NCGC00015209-06,
NCGC00015209-07,
NCGC00015209-08,
NCGC00015209-09,
NCGC00015209-12,
NCGC00091741-02,
NCGC00091741-03,
NCGC00260923-01,
60007-95-6,
ACM173547450,
BC200624,
HY-17420,
LS-99787,
NCI60_002097,
OR322611,
SC-22408,
SC-47258,
SC-91286,
N,O-propylenephosphoric acid ester diamide,
SBI-0050226.P003,
2-(4-FLUOROPHENYL)CYCLOPROPYL]AMINE,
AB0007927,
N,O-propylene-phosphoric acid ester diamide,
TC-063558,
TR-037249,
A2343,
EU-0100238,
FT-0624276,
N,O-trimethylenephosphoric acid ester diamide,
ST51005945,
3356-EP2269989A1,
3356-EP2270001A1,
3356-EP2270008A1,
3356-EP2270014A1,
3356-EP2270018A1,
3356-EP2270505A1,
3356-EP2272822A1,
3356-EP2272825A2,
3356-EP2272827A1,
3356-EP2275102A1,
3356-EP2275412A1,
3356-EP2275413A1,
3356-EP2275420A1,
3356-EP2277865A1,
3356-EP2277876A1,
3356-EP2280012A2,
3356-EP2281815A1,
3356-EP2281818A1,
3356-EP2287156A1,
3356-EP2289892A1,
3356-EP2289894A2,
3356-EP2292233A2,
3356-EP2292595A1,
3356-EP2292614A1,
3356-EP2292615A1,
3356-EP2292617A1,
3356-EP2295055A2,
3356-EP2295412A1,
3356-EP2295413A1,
3356-EP2295416A2,
3356-EP2295426A1,
3356-EP2295427A1,
3356-EP2298743A1,
3356-EP2298746A1,
3356-EP2298748A2,
3356-EP2298764A1,
3356-EP2298765A1,
3356-EP2298767A1,
3356-EP2298768A1,
3356-EP2298772A1,
3356-EP2298778A1,
3356-EP2298780A1,
3356-EP2301928A1,
3356-EP2301933A1,
3356-EP2305250A1,
3356-EP2305640A2,
3356-EP2305642A2,
3356-EP2305671A1,
3356-EP2305677A1,
3356-EP2305689A1,
3356-EP2308812A2,
3356-EP2308833A2,
3356-EP2308839A1,
3356-EP2308855A1,
3356-EP2308861A1,
3356-EP2311453A1,
3356-EP2311807A1,
3356-EP2311808A1,
3356-EP2311825A1,
3356-EP2311827A1,
3356-EP2311829A1,
3356-EP2311837A1,
3356-EP2311840A1,
3356-EP2311842A2,
3356-EP2314587A1,
3356-EP2314590A1,
3356-EP2316831A1,
3356-EP2316832A1,
3356-EP2316833A1,
3356-EP2316834A1,
3356-EP2371811A2,
3356-EP2374454A1,
C07888,
D07760,
W-5035,
27353-EP2269998A2,
27353-EP2272516A2,
27353-EP2275404A1,
27353-EP2275469A1,
27353-EP2284171A1,
27353-EP2287940A1,
27353-EP2292227A2,
27353-EP2295550A2,
27353-EP2298762A2,
27353-EP2298768A1,
27353-EP2308839A1,
27353-EP2314587A1,
27353-EP2371795A1,
AB00053446-09,
AB00053446-11,
AB00053446-12,
AB00053446_13,
AB00053446_14,
AB00053446_15,
005C978,
110841-EP2272827A1,
110841-EP2298305A1,
139301-EP2270008A1,
139301-EP2292617A1,
W-60377,
N,O-propylenephosphoric acid ester amide monohydrate,
SR-01000075737-1,
SR-01000075737-6,
BRD-A09722536-002-02-4,
UNII-6UXW23996M component CMSMOCZEIVJLDB-CQSZACIVSA-N,
2-(bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide,
2-[BIS(2-CHLOROETHYL)AMINO]TETRAHYDRO-2H-1,3,2-OXA,
2-[bis(2-chloroethyl)amino]-1,3,2$l;{5}-oxazaphosphinan-2-one,
2-[bis(2-chloroethyl)amino]-1,3,2-oxazaphosphaperhydroin-2-one,
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide #,
2-(bis(2-Chloroethyl)-amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide,
2-(di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane 2-oxide,
2-(Di(2-chloroethyl)amino)-2-phospha(V)-tetrahydro-2H-1,3-oxazine-2-one,
2-[Bis(2-chloroethyl)amino]tetrahydro-1,3,2-oxazaphosphorin-2-oxide,
2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide,
2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-,2-oxide,
N,N-Bis(.beta.-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide,
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide (H2O),
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide,
N,N-Bis-(.beta.-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid,
N-bis(beta-Chloroethyl)-N'O,trimethylenephos phoric acid ester diamide,
N-bis(beta-Chloroethyl)-N'O,trimethylenephosphoric acid ester diamide,
tatrahydro-2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide,
(+/-)-2-[Bis(2-chloroethyl)amino]tetrahydro-2 H-1,3,2-oxazaphosphorine 2-oxide,
(R)-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide,
(S)-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide,
2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide,
2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+)-,
2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (-)-,
2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate,
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide (9CI),
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-,2-oxide,
N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine,
N,N-bis(2-chloroethyl)-N'-(3-h ydroxypropyl)phosphorodiamidic acid intramol. ester,
N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)phosphorodiamidic acid intramol. ester,
N,N-Bis(2-Chloroethyl)tetrahydro-2H-1,3,2-Oxazaphosphorin-2-Amine, 2-Oxide,
Phosphorodiamidic acid,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester,
te trahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
tetrahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide,
InChI=1/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12),
Hexadrin,
Cyclophosphamide monohydrate,
cyclophosphamid-,
D-Cyclophosphamide,
L-Cyclophosphamide,
Cyclophosphamide hydrate,
Revimmune (TN),
Procytox (TN),
Cyclophosphamide-d4,
Endoxan (TN),
Neosar (TN),
(R)-Cyclophosphamide,
(S)-Cyclophosphamide,
(+)-Cyclophosphamide,
Cyclophosphamide [USP],
C7H15Cl2N2O2P,
D0CT9C,
UNII-6UXW23996M,
Cyclophosphamide, (R)-Isomer,
Cyclophosphamide, (S)-Isomer,
5,5'-Dideuterocyclophosphamide,
CID2907,
6UXW23996M,
C7-H15-Cl2-N2-O2-P,
NA2811,
UN2811,
CS-O-15107,
BRN 4678992,
6055-19-2,
B518,
N,N-bis(2-chloroethyl)-2-oxo-1,3,2,
C2236,
4-27-00-09750 (Beilstein Handbook Reference),
D003520,
CTX,
-2-[Bis amino]tetrahydro-2H-1,3,2-oxazaphosphorine2-oxide,
2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide,
60030-72-0,
CP,
CPA,
(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (R)-,
2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (S)-,
879324-66-0,
|
| Complexity | 212 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 260.025g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 14 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 261.083g/mol |
| Monoisotopic Mass | 260.025g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 41.6A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.6 |
| Symbol: | |
| Hazard Class | 6.1 |
| Hazard statements | H301-H350 |
| Packing Group | Ⅲ |
| Precautionary statements | P201-P301+P310-P308+P313 |
| UN Code | UN 2811 |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

